Emergence, Mechanism of Action, Clinical Applications and Challenges of Nanomedicine for Tumor Therapy
Journal Title: Diseases & Research - Year 2022, Vol 2, Issue 2
Abstract
With the increase in cancer cases globally, researchers have tried various methods to treat cancer. The study of nanomedicine, a novel drug form, has gained popularity in the medical community. Nanomedicine is a significant component of both nanotechnology and medical technology, and it has attracted the attention of both industry and academia worldwide. Compared with traditional chemotherapy drugs, nanomedicine is great application potential due to its advantages of enhanced drug solubility, high adsorption and biological activity, reduced toxicity, and reduced drug resistance. The drugs used to treat cancer, the idea, and purpose of nanomedicine, its use in clinical settings, and its difficulties are all covered in this article. Numerous mechanisms of nanomedicine therapy have been reported, although it is not yet widely used. In the future, combining nanoparticles with chemotherapeutic agents may be one of the most effective ways to treat cancer.
Authors and Affiliations
Yihang Chen, Jiajun Yu, Zhijie Wang, Juan Li
Keywords
Related Articles
- EP ID EP740153
- DOI 10.54457/DR.202202005
- Views 39
- Downloads 0
Research Advance in GP73 in the Clinical Diagnosis and Treatment of Patients with Chronic Hepatitis B
Golgi protein 73 (GP73) is a type II integrative membrane protein located in the cellular Golgi apparatus. Research shows, that in addition to protein processing, GP73 is involved in cell differentiation, intercellular s...
Salvage Therapy with Gilteritinib Plus Venetoclax for FLT3-ITD-Positive AML: A Case Report and Literature Review
FMS-like tyrosine kinase 3 (FLT3) mutations occur in around 30% of patients in acute myeloid leukemia (AML), and are generally associated with unfavorable outcomes. Gilteritinib is a highly specific second-generation cla...
Bioinformatics Analysis to Screen the Key Genes and Pathways in the Formation of Early T-cell Precursor Acute Lymphoblastic Leukemia
Purpose Early T-cell precursor acute lymphoblastic leukemia (EPT-ALL) is a rare type of ALL that shows genetic characteristics of both ALL and acute myeloid leukemia (AML) but has a poorer prognosis and a higher recurren...
Application of Immunoenhancing Radiotherapy in Treating Unresectable Intrahepatic Cholangiocarcinoma: A Case Report
Unresectable intrahepatic cholangiocarcinoma currently lacks standard treatment methods. This report presents a case where PET/CT scans showed a subcapsular mass in the right posterior lobe of the liver measuring 6.2 cm...
Review on Tumour Microenvironment Cell Types Associated with Metastatic Cancer
The Tumour microenvironment (TME) is a highly dynamic and perpetually altering entity of cancer development, progression, invasion, and dissemination. TME is interspersed with cellular components such as immune cells, bl...